Immediate Impact
34 standout
Citing Papers
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
2024 Standout
Renal cell carcinoma
2024 Standout
Works of C J Davis being referenced
Renal oncocytoma and carcinoma: failure of differentiation with CT.
1993
Air-flow limitation in myasthenia gravis. The effect of acetylcholinesterase inhibitor therapy on air-flow limitation.
1983
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| C J Davis | 476 | 357 | 194 | 13 | 614 | |
| William R. Morgan | 452 | 173 | 57 | 14 | 617 | |
| Raul Mancilla-Jimenez | 413 | 312 | 44 | 10 | 668 | |
| Han Jong Ahn | 308 | 229 | 33 | 9 | 582 | |
| Wayne H. Borges | 153 | 149 | 40 | 14 | 655 | |
| Anne M. Scruggs | 326 | 261 | 60 | 14 | 613 | |
| Edward M. Leter | 429 | 199 | 103 | 23 | 638 | |
| J. Wieslander | 452 | 121 | 124 | 21 | 732 | |
| Charles P. McKay | 270 | 158 | 30 | 16 | 605 | |
| J Maréchal | 447 | 270 | 50 | 15 | 679 | |
| Samuel M. Aguayo | 410 | 71 | 111 | 18 | 582 |
All Works
Loading papers...